leisure time
Previous article:
FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article: JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024
Next article: JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024
knowledge
focus
-
First recipient of genetically engineered pig kidney has died
2025-09-28 21:43 -
Boston Scientific acquires urology company Axonics for $3.7 billion
2025-09-28 21:02 -
Telehealth startups turn to complex chronic diseases
2025-09-28 20:38 -
Elevance, private equity launch primary care company
2025-09-28 20:27 -
Merck to acquire Harpoon Therapeutics for $680 million
2025-09-28 19:37 -
Google says AlphaFold 3 can map a vast universe of biomolecules
2025-09-28 19:35